Related references
Note: Only part of the references are listed.The evolution of bispecific antibodies
Nimish Gera
EXPERT OPINION ON BIOLOGICAL THERAPY (2022)
Development of Antibody-Based PROTACs for the Degradation of the Cell-Surface Immune Checkpoint Protein PD-L1
Adam D. Cotton et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2021)
Design and Efficacy of a Monovalent Bispecific PD-1/CTLA4 Antibody That Enhances CTLA4 Blockade on PD-1+ Activated T Cells
Simon J. Dovedi et al.
CANCER DISCOVERY (2021)
Bispecific antibodies
Ulrich Brinkmann et al.
SCIENCE (2021)
Elucidating heavy/light chain pairing preferences to facilitate the assembly of bispecific IgG in single cells
Kamal Kishore Joshi et al.
MABS (2019)
Overview of refinement procedures within REFMAC5: utilizing data from different sources
Oleg Kovalevskiy et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2018)
Developability Assessment of Engineered Monoclonal Antibody Variants with a Complex Self-Association Behavior Using Complementary Analytical and in Silico Tools
Lu Shan et al.
MOLECULAR PHARMACEUTICS (2018)
Design Principles for Bispecific IgGs, Opportunities and Pitfalls of Artificial Disulfide Bonds
Lilach Vaks et al.
ANTIBODIES (2018)
Efficient production of bispecific IgG of different isotypes and species of origin in single mammalian cells
Michael Dillon et al.
MABS (2017)
Computational design of a specific heavy chain/κ light chain interface for expressing fully IgG bispecific antibodies
K. J. Froning et al.
PROTEIN SCIENCE (2017)
Enhanced tumor-targeting selectivity by modulating bispecific antibody binding affinity and format valence
Yariv Mazor et al.
SCIENTIFIC REPORTS (2017)
Heavy and light chain pairing of bivalent quadroma and knobs-into-holes antibodies analyzed by UHR-ESI-QTOF mass spectrometry
Wolfgang Schaefer et al.
MABS (2016)
Bispecific antibodies
Roland E. Kontermann et al.
DRUG DISCOVERY TODAY (2015)
A Novel Antibody Engineering Strategy for Making Monovalent Bispecific Heterodimeric IgG Antibodies by Electrostatic Steering Mechanism
Zhi Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Improving target cell specificity using a novel monovalent bispecific IgG design
Yariv Mazor et al.
MABS (2015)
Insights into the molecular basis of a bispecific antibody's target selectivity
Yariv Mazor et al.
MABS (2015)
Alternative molecular formats and therapeutic applications for bispecific antibodies
Christoph Spiess et al.
MOLECULAR IMMUNOLOGY (2015)
Exploiting light chains for the scalable generation and platform purification of native human bispecific IgG
Nicolas Fischer et al.
NATURE COMMUNICATIONS (2015)
Generation of bispecific IgG antibodies by structure-based design of an orthogonal Fab interface
Steven M. Lewis et al.
NATURE BIOTECHNOLOGY (2014)
GA201 (RG7160): A Novel, Humanized, Glycoengineered Anti-EGFR Antibody with Enhanced ADCC and Superior In Vivo Efficacy Compared with Cetuximab
Christian A. Gerdes et al.
CLINICAL CANCER RESEARCH (2013)
Efficient generation of stable bispecific IgG1 by controlled Fab-arm exchange
Aran F. Labrijn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Overview of the CCP4 suite and current developments
Martyn D. Winn et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2011)
Immunoglobulin domain crossover as a generic approach for the production of bispecific IgG antibodies
Wolfgang Schaefer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Integration, scaling, space-group assignment and post-refinement
Wolfgang Kabsch
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
Enhancing Antibody Fc Heterodimer Formation through Electrostatic Steering Effects APPLICATIONS TO BISPECIFIC MOLECULES AND MONOVALENT IgG
Kannan Gunasekaran et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Coot:: model-building tools for molecular graphics
P Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2004)
The Protein Data Bank
HM Berman et al.
NUCLEIC ACIDS RESEARCH (2000)